News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Hutson Nancy J
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| Hutson Nancy J (Director) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Bought 10,000 shares
@ $0.86, valued at
$8.6k
|
|
| 05/19/2023 |
4
| Hutson Nancy J (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Exercised 3,750 restricted stock units
@ $0 |
|
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Hutson Nancy J (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Granted 17,500 options to buy
@ $0.8419, valued at
$14.7k
Granted 3,750 restricted stock units
@ $0 |
|
| 11/08/2021 |
4
| Hutson Nancy J (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Exercised 24,860 options to buy
@ $2.26, valued at
$56.2k
Exercised 1,500 options to buy
@ $3.15, valued at
$4.7k
Exercised 7,400 options to buy
@ $3.15, valued at
$23.3k
|
|
| 11/02/2021 |
4
| Hutson Nancy J (Director) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Exercised 25,000 options to buy
@ $2, valued at
$50k
Exercised 15,000 options to buy
@ $2.09, valued at
$31.4k
|
|
| 10/19/2021 |
4
| Hutson Nancy J (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 105,000 shares
@ $15.4, valued at
$1.6M
Exercised 30,000 options to buy
@ $2.91, valued at
$87.3k
Exercised 30,000 options to buy
@ $5.13, valued at
$153.9k
Exercised 15,000 options to buy
@ $1.71, valued at
$25.7k
Exercised 30,000 options to buy
@ $3.22, valued at
$96.6k
|
|
| 08/19/2021 |
4
| Hutson Nancy J (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Bought 3,000 shares
@ $3.08, valued at
$9.2k
|
|
| 08/17/2021 |
4
| Hutson Nancy J (Director) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Bought 3,000 shares
@ $5.68, valued at
$17k
|
|
| 06/15/2021 |
4
| Hutson Nancy J (Director) has filed a Form 4 on Endo International plc|
Txns:
| Granted 47,924 shares
@ $0
Paid exercise price by delivering 23,003 shares
@ $6.26, valued at
$144k
|
|
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Hutson Nancy J (Director) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Granted 25,000 options to buy
@ $3.11, valued at
$77.8k
|
|
| 06/04/2021 |
4
| Hutson Nancy J (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Granted 14,000 options to buy
@ $3.53, valued at
$49.4k
|
|
| 06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2020 |
4
| Hutson Nancy J (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 978 shares
@ $5.11, valued at
$5k
|
|
| 09/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2020 |
4
| Hutson Nancy J (Director) has filed a Form 4 on Endo International plc|
Txns:
| Granted 25,511 shares
@ $0
Paid exercise price by delivering 12,245 shares
@ $3.43, valued at
$42k
|
|
| 06/05/2020 |
4
| Hutson Nancy J (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Granted 16,000 options to buy
@ $4.86, valued at
$77.8k
|
|
| 06/03/2020 |
4
| Hutson Nancy J (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 2,224 shares
@ $4.495, valued at
$10k
|
|
| 05/21/2020 |
4
| Hutson Nancy J (Director) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Bought 5,000 shares
@ $1.85, valued at
$9.3k
|
|
| 05/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/23/2020 |
4
| Hutson Nancy J (Director) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Granted 30,000 options to buy
@ $2.09, valued at
$62.7k
|
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2019 |
4
| Hutson Nancy J (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 3,508 shares
@ $2.85, valued at
$10k
|
|
| 11/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/04/2019 |
4
| Hutson Nancy J (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 3,344 shares
@ $2.99, valued at
$10k
|
|
| 06/14/2019 |
4
| Hutson Nancy J (Director) has filed a Form 4 on Endo International plc|
Txns:
| Granted 53,812 shares
@ $0
Paid exercise price by delivering 25,829 shares
@ $4.46, valued at
$115.2k
|
|
| 05/31/2019 |
4
| Hutson Nancy J (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 30,000 options to buy
@ $2.91, valued at
$87.3k
|
|
|
|
|